We were captivated by Madison Honey's remarkable lecture at the AD/PD 2024 Symposium. As a researcher from Prof. Charlotte Teunissen's Neurochemistry Lab at Amsterdam UMC, she presented a lecture titled "Development of a prototype point-of-care test using FOPPR technology for ultrasensitive detection of Neurofilament Light Chain in plasma."

Madison demonstrated the use of Instant NanoBiosensors' FOPPR technology, covering everything from antibody selection and analysis to ultra-sensitive plasma testing. This is not only a paradigm of technological innovation but also brings new light to the diagnosis and research of neurodegenerative diseases. The potential of this technology will undoubtedly have a profound impact on our understanding and treatment of neurodegenerative diseases.

Information on: https://adpd2024.kenes.com/

The AD/PD Conference is a prestigious event where leading experts convene to delve into the newest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s diseases. It offers a platform for revealing groundbreaking discoveries and discussing the latest advancements in therapies.

The Conference offers a great opportunity to connect with and learn from top international experts, discuss the latest news and trends in the field, and present your work to receive valuable feedback.